Local low-dose IL-2 therapy

Hepatogastroenterology. 1999 May:46 Suppl 1:1280-6.

Abstract

Interleukin-2 (IL-2) is a powerful drug for treating cancer. However, it is only powerful if it is properly applied. That is, IL-2 should be applied at the tumor site, because at the transition of normal and malignant tissue are the tumor infiltrating cells. These should be activated by IL-2. Local application implies that IL-2 can be used in relatively low doses. It is becoming clear that even a single injection of IL-2 can cure cancer. IL-2 can also enhance the therapeutic effects of irradiation and Cisplatin. Locally applied IL-2 therapy is virtually non-toxic.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinoma, Squamous Cell / therapy
  • Cattle
  • Cisplatin / therapeutic use
  • Combined Modality Therapy
  • Dose-Response Relationship, Drug
  • Eye Neoplasms / therapy
  • Humans
  • Injections, Intralesional
  • Interleukin-2 / administration & dosage*
  • Lymphoma / therapy
  • Mammary Neoplasms, Experimental / therapy
  • Mast-Cell Sarcoma / therapy
  • Mice
  • Mice, Inbred DBA
  • Neoplasm Transplantation
  • Neoplasms / therapy*
  • Time Factors
  • Tumor Cells, Cultured
  • Urinary Bladder Neoplasms / therapy

Substances

  • Interleukin-2
  • Cisplatin